The drug is used to treat osteoporosis in postmenopausal women at high risk of a fracture or who have not responded to similar therapies.
Tymlos, an intravenous drug, carries a box warning over the risk of bone cancer.
More articles on supply chain:
FDA approves RFID device to locate breast lumps
9 strategies to lower drug costs, as ranked by public support
Poll: GOP prioritizes lower drug prices over reducing government’s role in healthcare
Register to Attend Webinar
Presenters:
Mark Miller, Naviant|Jason Bui, UiPath|Jessica Wilborne, BlueCross BlueShield of North Carolina|Colleen Bubnack, UiPath
Next Up in Supply Chain
-
Phoenix-based Valleywise Health has become the first hospital in Arizona to implement the LifeBubble Umbilical Line Securement System for premature…
-
Vizient has unveiled three solutions designed to help health systems address performance gaps across the supply chain lifecycle. The tools…
-
Vizient has recognized suppliers for service, partnership and performance supporting its healthcare provider clients. Here are the suppliers recognized across…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
